{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T19:40:13Z","timestamp":1777837213260,"version":"3.51.4"},"reference-count":70,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2018,12,12]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Beh\u00e7et\u2019s Disease (BD) is characterized by numerous systemic manifestations and is known for its ability to affect both, arteries and the veins. However, the etiology of BD is only partially understood, and previous studies have demonstrated a role for genetic and epigenetic factors that contribute to disease pathophysiology. Several studies have implicated T cells and monocytes in the pathogenesis of BD especially when these cells are stimulated by heat shock proteins and streptococcal antigen. Furthermore, during disease exacerbations adenosine deaminase has an important role in activating lymphocyte proliferation, maturation, and differentiation in BD. This article presents a review of the published literature mainly from the last 20 years. The topics of main concern were the role of genetic and epigenetic factors as contributing factors in disease pathophysiology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result and Conclusion:<\/jats:title><jats:p>The authors used MeSH terms \u201cBeh\u00e7et\u2019s disease\u201d with \u201cpathophysiology,\u201d \u201cpathogenesis,\u201d \u201cgenetic\u201d or \u201cepigenetic\u201d to search the PubMed database. All the relevant studies identified were included and are described according to the aforementioned subheadings.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573397114666180521090335","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T08:51:18Z","timestamp":1526979078000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetics and Epigenetics Mechanism in the Pathogenesis of Beh\u00e7et\u2019s Disease"],"prefix":"10.2174","volume":"15","author":[{"given":"Jibran Sualeh","family":"Muhammad","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ishaq","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jinnah Medical College Hospital, Korangi, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Biological and Biomedical Sciences, the Aga Khan University Hospital, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"Sakane T.","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G. Beh\u00e7et\u2019s disease.","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1002\/art.24149","volume":"58","author":"Mahr A.","year":"2008","unstructured":"Mahr A, Belarbi L, Wechsler B. Population based prevalence study of Beh\u00e7et\u2019s disease: Differences by ethnic origin and low variation by age at immigration.","journal-title":"Arthritis Rheumatol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1744-313X.2007.00655.x","volume":"34","author":"Gunesacar R.","year":"2007","unstructured":"Gunesacar R, Erken E, Bozkurt B. Analysis of CD28 and CTLA 4 gene polymorphisms in Turkish patients with Behcet\u2019s disease.","journal-title":"Int J Immunogenet"},{"key":"ref=4","first-page":"506","volume":"16","author":"Mizushima Y.","year":"1989","unstructured":"Mizushima Y. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Beh\u00e7et\u2019s disease- A multicenter study.","journal-title":"J Rheumatol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.60.11.996","volume":"60","author":"Direskeneli H.","year":"2001","unstructured":"Direskeneli H. Beh\u00e7et9s disease: Infectious aetiology, new autoantigens, and HLA-B51.","journal-title":"Ann Rheum Dis"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/0962935031000097754","volume":"12","author":"Erkili\u00e7 K.","year":"2003","unstructured":"Erkili\u00e7 K, Evereklioglu C, \u00c7ekmen M, \u00d6zkiris A, Duygulu F, Dogan H. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Beh\u00e7et\u2019s disease: Original contributions\/clinical and laboratory investigations.","journal-title":"Mediators Inflamm"},{"key":"ref=7","volume":"28","author":"Erden F.","year":"2017","unstructured":"Erden F, Karagoz H, Avci A. Which one is best? platelet\/lymphocyte ratio, neutrophil\/lymphocyte ratio or both in determining deep venous thrombosis in behcet\u2019s disease?","journal-title":"Biomed Res"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"Direskeneli H.","year":"2006","unstructured":"Direskeneli H. Autoimmunity vs autoinflammation in Behcet\u2019s disease: Do we oversimplify a complex disorder?","journal-title":"Rheumatology"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","volume":"48","author":"Kartal Durmazlar S.P.","year":"2009","unstructured":"Kartal Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A. Significance of serum interleukin 8 levels in patients with Behcet\u2019s disease: High levels may indicate vascular involvement.","journal-title":"Int J Dermatol"},{"key":"ref=10","first-page":"1544","volume":"20","author":"Mege J.","year":"1993","unstructured":"Mege J, Dilsen N, Sanguedolce V. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects.","journal-title":"J Rheumatol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","volume":"44","author":"Akman-Demir G.","year":"2008","unstructured":"Akman-Demir G, T\u00fcz\u00fcn E, \u0130\u00e7\u00f6z S, Ye\u015filot N. Interleukin-6 in neuro-Beh\u00e7et\u2019s disease: Association with disease subsets and long-term outcome.","journal-title":"Cytokine"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","volume":"50","author":"Ben Ahmed M.","year":"2004","unstructured":"Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh\u00e7et\u2019s disease.","journal-title":"Arthritis Rheumatol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"de Chambrun M.P.","year":"2012","unstructured":"de Chambrun MP, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Behcet\u2019s disease.","journal-title":"Autoimmun Rev"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"Hamzaoui K.","year":"2002","unstructured":"Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza MH, Ayed K. Cytokine profile in Beh\u00e7et\u2019s disease patients.","journal-title":"Scand J Rheumatol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3476(99)70333-1","volume":"135","author":"Kon\u00e9-Paut I.","year":"1999","unstructured":"Kon\u00e9-Paut I, Geisler I, Wechsler B. Familial aggregation in Beh\u00e7et\u2019s disease: High frequency in siblings and parents of pediatric probands.","journal-title":"J Pediatr"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2249.2004.02536.x","volume":"137","author":"Yu H.","year":"2004","unstructured":"Yu H, Lee D, Seo J. The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Beh\u00e7et\u2019s uveitis.","journal-title":"Clin Exp Immunol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/annrheumdis-2011-200288","volume":"72","author":"Lee Y.J.","year":"2012","unstructured":"Lee YJ, Horie Y, Wallace GR. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet\u2019s disease.","journal-title":"Ann Rheum Dis"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"Sfikakis P.","year":"2001","unstructured":"Sfikakis P, Theodossiadis P, Katsiari C, Kaklamanis P, Markomichelakis N. Effect of infliximab on sight-threatening panuveitis in Behcet\u2019s disease.","journal-title":"Lancet"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","volume":"50","author":"Evereklioglu C.","year":"2005","unstructured":"Evereklioglu C. Current concepts in the etiology and treatment of Beh\u00e7et disease.","journal-title":"Surv Ophthalmol"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","volume":"142","author":"Ahn J.K.","year":"2006","unstructured":"Ahn JK, Yu HG, Chung H, Park YG. Intraocular cytokine environment in active Beh\u00e7et uveitis.","journal-title":"Am J Ophthalmol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2249.2000.01176.x","volume":"120","author":"Kurhan Yavuz S.","year":"2000","unstructured":"Kurhan Yavuz S, Direskeneli H. Anti MHC autoimmunity in Beh\u00e7et\u2019s disease: T cell responses to an HLA B derived peptide cross reactive with retinal S antigen in patients with uveitis.","journal-title":"Clin Exp Immunol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1067\/mjd.2002.118338","volume":"46","author":"Evereklioglu C.","year":"2002","unstructured":"Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M. Increased nitric oxide production in patients with Beh\u00e7et\u2019s disease: Is it a new activity marker?","journal-title":"J Am Acad Dermatol"},{"key":"ref=23","first-page":"3480","volume":"41","author":"de Smet M.D.","year":"2000","unstructured":"de Smet MD, Dayan M. Prospective determination of T-cell responses to S-antigen in Beh\u00e7et\u2019s disease patients and controls.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=24","author":"Balta S.","year":"2014","unstructured":"Balta S, Balta I, Demirkol S, Ozturk C, Demir M.","journal-title":"Endothelial function and Behcet disease"},{"key":"ref=25","first-page":"449","volume":"36","author":"Sahin M.","year":"2006","unstructured":"Sahin M, Arslan C, Naziroglu M. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet\u2019s disease.","journal-title":"Ann Clin Lab Sci"},{"key":"ref=26","unstructured":""},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archopht.125.2.246","volume":"125","author":"Nakao K.","year":"2007","unstructured":"Nakao K, Isashiki Y, Sonoda S, Uchino E, Shimonagano Y, Sakamoto T. Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behcet disease.","journal-title":"Arch Ophthalmol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0049-3848(02)00006-3","volume":"105","author":"Kiraz S.","year":"2002","unstructured":"Kiraz S. Ertenli Ih, \u00d6zt\u00fcrk MA, Haznedaro\u011flu IbC, \u00c7elik Is, \u00c7alg\u00fcneri M. Pathological haemostasis and \u2018prothrombotic state\u2019in Beh\u00e7et\u2019s disease.","journal-title":"Thromb Res"},{"key":"ref=29","first-page":"89","volume":"33","author":"\u00dcsk\u00fcdar O.","year":"2005","unstructured":"\u00dcsk\u00fcdar O, Erdem A, Demiro\u011flu H, Dikmeno\u011flu N. Decreased erythrocyte deformability in Beh\u00e7et\u2019s disease.","journal-title":"Clin Hemorheol Microcirc"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2141.2004.05072.x","volume":"126","author":"Navarro S.","year":"2004","unstructured":"Navarro S, Ricart JM, Medina P. Activated protein C levels in Beh\u00e7et\u2019s disease and risk of venous thrombosis.","journal-title":"Br J Haematol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1076029606293430","volume":"12","author":"Akar S.","year":"2006","unstructured":"Akar S, \u00d6zcan MA, Ate\u015f H. Circulated activated platelets and increased platelet reactivity in patients with Beh\u00e7et\u2019s disease.","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-4632.2009.04229.x","volume":"49","author":"Tatlican S.","year":"2010","unstructured":"Tatlican S, Duran FS, Eren C. Reduced erythrocyte deformability in active and untreated Beh\u00e7et\u2019s disease patients.","journal-title":"Int J Dermatol"},{"key":"ref=33","unstructured":""},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jbspin.2010.02.022","volume":"77","author":"Caramaschi P.","year":"2010","unstructured":"Caramaschi P, Poli G, Bonora A. A study on thrombophilic factors in Italian Behcet\u2019s patients.","journal-title":"Joint Bone Spine"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07078.x","volume":"141","author":"Ricart J.M.","year":"2008","unstructured":"Ricart JM, Ram\u00f3n LA, Vay\u00e1 A. Fibrinolytic inhibitor levels and polymorphisms in Beh\u00e7et disease and their association with thrombosis.","journal-title":"Br J Haematol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/ard.2003.014241","volume":"63","author":"Leiba M.","year":"2004","unstructured":"Leiba M, Seligsohn U, Sidi Y. Thrombophilic factors are not the leading cause of thrombosis in Beh\u00e7et\u2019s disease.","journal-title":"Ann Rheum Dis"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.thromres.2007.05.013","volume":"121","author":"Song S.H.","year":"2008","unstructured":"Song SH, Kim HK, Park MH, Cho H-I. Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation.","journal-title":"Thromb Res"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10528-013-9621-x","volume":"51","author":"Vaccarino L.","year":"2013","unstructured":"Vaccarino L, Triolo G, Accardo-Palombo A. Pathological implications of Th1\/Th2 cytokine genetic variants in Behcet\u2019s disease: Data from a pilot study in a Sicilian population.","journal-title":"Biochem Genet"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2133.2005.06543.x","volume":"153","author":"Turkmen S.","year":"2005","unstructured":"Turkmen S, Ayabakan H, Buldanlioglu S. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Beh\u00e7et\u2019s disease.","journal-title":"Br J Dermatol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00296-001-0148-9","volume":"21","author":"Saglam K.","year":"2002","unstructured":"Saglam K, Yilmaz IM, Saglam A, Ulgey M, Bulucu F, Baykal Y. Levels of circulating intercellular adhesion molecule-1 in patients with Beh\u00e7et\u2019s disease.","journal-title":"Rheumatol Int"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10067-006-0512-y","volume":"26","author":"Ate\u015f A.","year":"2007","unstructured":"Ate\u015f A, Tiryaki OA, \u00d6lmez \u00dc, Tutkak H. Serum-soluble selectin levels in patients with Beh\u00e7et\u2019s disease.","journal-title":"Clin Rheumatol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2249.2006.03253.x","volume":"147","author":"Lee M.","year":"2007","unstructured":"Lee M, Hooper L, Kump L. Interferon \u03b2 and adhesion molecules (E selectin and s intracellular adhesion molecule 1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll like receptor 3 signalling.","journal-title":"Clin Exp Immunol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1248\/bpb.24.733","volume":"24","author":"Yamashita S.","year":"2001","unstructured":"Yamashita S, Suzuki A, Kamada M, Yanagita T, Hirohata S, Toyoshima S. Possible physiological roles of proteolytic products of actin in neutrophils of patients with Behcet\u2019s disease.","journal-title":"Biol Pharm Bull"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10715769809097874","volume":"28","author":"Yoshida T.","year":"1998","unstructured":"Yoshida T, Tanaka M, Sotomatsu A, Okamoto K, Hirai S. Serum of Behqet\u2019s Disease Enhances Super oxide Production of Normal Neutrophils.","journal-title":"Free Radic Res"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.140.5.570","volume":"140","author":"Kawakami T.","year":"2004","unstructured":"Kawakami T, Ohashi S, Kawa Y. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: Implication in neutrophil apoptosis dysfunction.","journal-title":"Arch Dermatol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","volume":"151","author":"Yazici C.","year":"2004","unstructured":"Yazici C, K\u00f6se K, Cali\u015f M, Demir M, Kirnap M, Ate\u015f F. Increased advanced oxidation protein products in Behcet\u2019s disease: A new activity marker?","journal-title":"Br J Dermatol"},{"key":"ref=47","first-page":"S52","volume":"27","author":"Hamzaoui K.","year":"2009","unstructured":"Hamzaoui K, Ma\u00eetre B, Hamzaoui A. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Beh\u00e7et\u2019s disease.","journal-title":"Clin Exp Rheumatol"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/1529-0131(200111)44:11<2693::AID-ART449>3.0.CO;2-M","volume":"44","author":"G\u00fcl A.","year":"2001","unstructured":"G\u00fcl A, Hajeer AH, Worthington J, Ollier WE, Silman AJ. Linkage mapping of a novel susceptibility locus for Beh\u00e7et\u2019s disease to chromosome 6p22 23.","journal-title":"Arthritis Rheumatol"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","volume":"64","author":"Takeuchi M.","year":"2015","unstructured":"Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behcet\u2019s disease: A comprehensive review.","journal-title":"J Autoimmun"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/eji.1830241103","volume":"24","author":"Wildner G.","year":"1994","unstructured":"Wildner G, Thurau SR. Cross reactivity between an HLA B27 derived peptide and a retinal autoantigen peptide: A clue to major histocompatibility complex association with autoimmune disease.","journal-title":"Eur J Immunol"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.humimm.2006.08.294","volume":"67","author":"Gebreselassie D.","year":"2006","unstructured":"Gebreselassie D, Spiegel H, Vukmanovic S. Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B* 5101 with peptides.","journal-title":"Human immunology"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Kirino Y.","year":"2013","unstructured":"Kirino Y, Bertsias G, Ishigatsubo Y. Genome-wide association analysis identifies new susceptibility loci for Behcet\u2019s disease and epistasis between HLA-B [ast] 51 and ERAP1.","journal-title":"Nat Genet"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/1547691X.2017.1346008","volume":"14","author":"Salmaninejad A.","year":"2017","unstructured":"Salmaninejad A, Gowhari A, Hosseini S. Genetics and immunodysfunction underlying Beh\u00e7et\u2019s disease and immunomodulant treatment approaches.","journal-title":"J Immunotoxicol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","volume":"128","author":"Goldberg A.D.","year":"2007","unstructured":"Goldberg AD, Allis CD, Bernstein E. Epigenetics: A landscape takes shape.","journal-title":"Cell"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1196\/annals.1422.015","volume":"1108","author":"Balada E.","year":"2007","unstructured":"Balada E, Ordiros J, Vilardelltarr\u00e9s M. DNA methylation and systemic lupus erythematosus.","journal-title":"Ann N Y Acad Sci"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"Deaton A.M.","year":"2011","unstructured":"Deaton AM, Bird A. CpG islands and the regulation of transcription.","journal-title":"Genes Dev"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)81532-9","volume":"99","author":"Bird A.P.","year":"1999","unstructured":"Bird AP, Wolffe AP. Methylation-induced repression-belts, braces, and chromatin.","journal-title":"Cell"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)81156-3","volume":"93","author":"Surani M.A.","year":"1998","unstructured":"Surani MA. Imprinting and the initiation of gene silencing in the germ line.","journal-title":"Cell"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/icb.2015.18","volume":"93","author":"Gupta B.","year":"2015","unstructured":"Gupta B, Hawkins RD. Epigenomics of autoimmune diseases.","journal-title":"Immunol Cell Biol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nsmb1337","volume":"14","author":"Bhaumik S.R.","year":"2007","unstructured":"Bhaumik SR, Smith E, Shilatifard A. Covalent modifications of histones during development and disease pathogenesis.","journal-title":"Nat Struct Mol Biol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"Kouzarides T.","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function.","journal-title":"Cell"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1073\/pnas.94.4.1298","volume":"94","author":"Mizuki N.","year":"1997","unstructured":"Mizuki N, Ota M, Kimura M. Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with Behcet disease.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/art.21060","volume":"52","author":"Karasneh J.","year":"2005","unstructured":"Karasneh J, G\u00fcl A, Ollier WE, Silman AJ, Worthington J. Whole genome screening for susceptibility genes in multicase families with Beh\u00e7et\u2019s disease.","journal-title":"Arthritis Rheumatol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","volume":"37","author":"G\u00fcl A.","year":"2015","unstructured":"G\u00fcl A. editor Pathogenesis of Beh\u00e7et\u2019s disease: Autoinflammatory features and beyond.","journal-title":"Semin Immunopathol"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","volume":"14","author":"Consolandi C.","year":"2015","unstructured":"Consolandi C, Turroni S, Emmi G. Beh\u00e7et\u2019s syndrome patients exhibit specific microbiome signature.","journal-title":"Autoimmun Rev"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/BOR.0000000000000189","volume":"27","author":"Ombrello M.J.","year":"2015","unstructured":"Ombrello MJ, Kastner DL, Remmers EF. Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: Genetics.","journal-title":"Curr Opin Rheumatol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1348-0421.1992.tb02083.x","volume":"36","author":"Yokota K.","year":"1992","unstructured":"Yokota K, Hayashi S, Fujii N. Antibody response to oral streptococci in Beh\u00e7et\u2019s disease.","journal-title":"Microbiol Immunol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000246336","volume":"192","author":"Calg\u00fcneri M.","year":"1996","unstructured":"Calg\u00fcneri M, Ertenli I, Kiraz S, Erman M, Celik I. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Beh\u00e7et\u2019s disease.","journal-title":"Dermatology"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajmg.1438","volume":"102","author":"Kogan A.","year":"2001","unstructured":"Kogan A, Shinar Y, Lidar M. Common MEFV mutations among Jewish ethnic groups in Israel: High frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state.","journal-title":"Am J Med Genet A"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/art.38409","volume":"66","author":"Hughes T.","year":"2014","unstructured":"Hughes T, Ture Ozdemir F, Alibaz Oner F, Coit P, Direskeneli H, Sawalha AH. Epigenome wide scan identifies a treatment responsive pattern of altered dna methylation among cytoskeletal remodeling genes in monocytes and cd4+ t cells from patients with beh\u00e7et\u2019s disease.","journal-title":"Arthritis Rheumatol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/162291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:08:18Z","timestamp":1661299698000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/162291\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397114666180521090335","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}